Novartis (NYSE: NVS) reported Q2 EPS of $1.97, $0.13 better than the analyst estimate of $1.84. Revenue for the quarter came in at $12.51 billion versus the consensus estimate of $12.35 billion.

2024 OUTLOOK

Net sales Expected to grow high single to low double-digit (unchanged).
Core operating income Expected to grow mid- to high teens (from low double-digit to mid-teens)

For earnings history and earnings-related data on Novartis (NVS) click here.